Vitaspring Biomedical VSBC
OTC VSBC
$0.02 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Vitaspring Biomedical (VSBC) Cash from Investing Activities (2017 - 2022)

Updated

Vitaspring Biomedical (VSBC) reported Cash from Investing Activities of -$145,993 for fiscal Q4 2022 (quarter ended Jan 31, 2022).

Analysis

Vitaspring Biomedical (VSBC) Cash from Investing Activities (2017 - 2022) Analysis & Trends

For FY2022 (ended Jan 31, 2022), Vitaspring Biomedical posted Cash from Investing Activities of -$72,997.

  • By fiscal year, Cash from Investing Activities came in at -$2,249 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -8.30 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -2.71 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -10.22 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -1.32 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.89 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -649.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -244.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -2.03 Bn
10 Vitaspring Biomedical 4.14 Mn 4.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2022 -145,993.00
Oct 31, 2021 23,211.00
Apr 30, 2017 -2,249.00
API Access

Vitaspring Biomedical Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=VSBC&period=max&api_key=YOUR_API_KEY